Deals Shaping The Medical Industry, December 2012
Executive Summary
Derived from Strategic Transactions, EBI’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals– and then categorized by type –Acquisition, Alliance, or Financing.
You may also be interested in...
CIR Expert Panel’s September Safety Findings, Final 2023 Priorities
Cosmetic Ingredient Review’s panel of independent experts will be highly focused on botanical ingredients in 2023 – a sign of the times, it says. At its September meeting, the panel finalized six ingredient safety reports, advanced four tentative reports, and issued an insufficient data announcement for Phenyl-Substituted Methicones.
US Regulatory Roundup – September 2022: Philips Troubles, Software And User Fees
The ten most popular stories about US regulatory issues published by Medtech Insight last month were a mixed bag, with a Philips recall taking the top spot and stories about AI, user fees, and more adding to the list.
Execs On The Move: Dentsply Gets New CEO And CFO
An interactive view of medtech executive changes from the month of September 2022. Major changes include Dentsply's appointment of a new CEO and CFO, a new CTO at Accuray and a re-shuffle at Pulse Biosciences.